Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

3.770

-0.030 (-0.79%)

At close: Dec 5, 2025, 4:00 PM EST

3.610

-0.160 (-4.24%)

After-hours: Dec 5, 2025, 5:01 PM EST

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $15.99 million as of December 5, 2025. Its market cap has decreased by -78.10% in one year.

Market Cap

15.99M

Enterprise Value

3.86M

1-Year Change

-78.10%

Ranking

#5046

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $15.99M, an increase of 113.14%. That is a compound annual growth rate of 3.84%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	16.10M	30.89%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	908.36B
Johnson & Johnson	487.83B
AbbVie	404.22B
UnitedHealth Group	302.09B
AstraZeneca	279.81B
Novartis AG	255.73B
Merck & Co.	250.41B
Abbott Laboratories	218.05B

Market Cap Rankings